Back

Timing of P2Y12 inhibitor administration in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Personalising antithrombotic therapy in percutaneous coronary intervention for acute coronary syndromes: balancing ischaemic protection and bleeding risk Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Theoni Theodoropoulou

Hippokration General Hospital, Athens (Greece)

5 More presentations in this session

Presentation thumbnail
Impact of intravascular imaging guidance on the effects of aspirin-free strategy for percutaneous coronary intervention for acute coronary syndrome: a post-hoc analysis from the STOPDAPT-3 trial
Doctor K. Takabayashi (Shiga, JP)
Abstract Slides
Presentation thumbnail
Temporal trends in the use of P2Y12 inhibitors over 15 years and their impact on in-hospital bleeding and mortality among patients with acute myocardial infarction in Switzerland
Mr J. Loosli (Zurich, CH)
Abstract Slides
Presentation thumbnail
Impact of routine cardiovascular medications on contrast induced nephropathy post percutaneous coronary intervention: a national experience
Doctor O. Alameen (Doha, QA)
Abstract Slides
Presentation thumbnail
Standard versus extended dual antiplatelet therapy after pci in acute coronary syndrome: a systematic review and meta-analysis
Mr A. Gasca (Cali, CO)
Abstract Slides
Presentation thumbnail
Early aspirin withdrawal to P2Y12 monotherapy after PCI for ACS: a systematic review and meta-analysis of randomized controlled trials
Professor M. Saffi (Porto Alegre, BR)
Abstract Slides

Access the full session

Session thumbnail
Personalising antithrombotic therapy in percutaneous coronary intervention for acute coronary syndromes: balancing ischaemic protection and bleeding risk

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
The effect of P2Y12 inhibitor pretreatment vs. no pretreatment on major bleeding among patients with NSTE-ACS: an updated meta-analysis and meta-regression pooling 41,548 patients from 11 studies
27 August 2021
thumbnail
Congress Presentation
Glycaemic status and reperfusion injury in patients with ST-segment elevation myocardial infarction
29 August 2021
thumbnail
Congress Presentation
Complete revascularization for patients with multivessel coronary artery disease and ST-segment elevation myocardial infarction after the COMPLETE trial: A meta-analysis of randomized controlled trial
31 August 2020
thumbnail
Congress Presentation
Efficacy of early versus late b-blocker administration after primary PCI
26 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources